Tramadol, buy tramadol, antibiotics, Weight Loss drugs, weight loss herbs, weight loss herbal formula, weight loss, hair loss, hair growth, baldness, Rx Online, pharmaceuticals, DHEA, Lutein, Prescription, Prescription drug, prescription medications, follicle.

DreamPharm Products:

Lutein-20||Herbs for headache, fever, and migraine || Milk thistle||Saw palmetto|| Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract|| Ginseng and Ginkgo||Hair Million|| DHEA||Coenzyme Q10|| Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.|| Weight loss herbal formula for menopause and pms||Ginkgo biloba|| Colon cleansing, Laxative||ViaVita, Lecithin for healthy liver

Fatty acids resources:

Pathogen research abs 1 || Pathogen research abs 2 || Pathogen research abs 3 || Pathogen research abs 4 || Pathogen research abs 5 || Hormone and endocrine research abs 1 || Hormone and endocrine research abs 2 || Hormone and endocrine research abs 3 || Hormone and endocrine research abs 4 || Hormone and endocrine research abs 5 || Follicle and follicular cells research abs 1

Int J Childbirth Educ. 1992 Feb;7(1):28-30.
Birth control update for childbirth educators.

Livingston C.

PIP: Since the last in a series of childbirth education classes discusses contraception, educators must know about various family planning methods. Oral contraceptives (OCs) comprise combined OCs, phasic OCs, and minipills. Combined OCs inhibit secretion of gonadotropin-releasing hormone, which in turn keeps the follicle-stimulating hormone from inducing the ovarian follicle to grow and keeps luteinizing hormones from activating ovulation. They also thicken cervical mucus. Minipills also thicken cervical mucus and render the endometrium unreceptive to fertilized egg implantation. They do not always inhibit ovulation, however. OCs can induce side effects, such as nausea, hypertension, increased risk of atherosclerosis, and fatigue. The IUD prevents pregnancy either by inhibiting implantation of a fertilized egg or by an inflammatory reaction of the endometrium resulting in a release of macrophages which may destroy sperm. The no-longer-produced Dalkon Shield IUD increased the risk of pelvic inflammatory disease and damaged the reputation of other IUDs. Rare IUD complications are uterine perforation, salpingitis, tubal scarring, pelvic inflammatory disease, and infertility. Diaphragms, cervical film, and condoms serve as barriers between the egg and sperm. The main problem with barrier methods is the increased risk of developing toxic shock syndrome. Spermicide increase the effectiveness of diaphragms, cervical caps, and condoms. Vasectomy keeps sperm from arriving at storage sites. Shortterm side effects are swelling, discomfort, and occasional rejoining of the cut ends of the vas. Research hints at a link between vasectomy and prostate cancer. Some complications of tubal ligation are urinary tract infections, accidental electrical burns, and pelvic infections. Natural family planning methods include withdrawal, the rhythm method, and the sypto-thermal method. Controversial injectable contraceptives are Depo-Provera (medroxyprogesterone acetate) and Noristerate (norethisterone enanthate).

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12345029&dopt=Abstract

J Mol Endocrinol. 1999 Apr;22(2):151-9.
Generating FSH antagonists and agonists through immunization against FSH receptor N-terminal decapeptides.

Abdennebi L, Couture L, Grebert D, Pajot E, Salesse R, Remy JJ.

Unite Recepteurs et Communications Cellulaires, INRA-Biotechnologies, 78352 Jouy-en-Josas, France.

Follicle-stimulating hormone (FSH) via interaction with G-protein coupled specific receptors plays a central role in the control of gametogenesis in mammals of both sexes. In females, FSH is crucial for follicle growth, follicle maturation and ovulation. FSH receptors, together with luteinizing hormone-chorionic gonadotropin and thyrotropin receptors belong to a subfamily of structurally related receptors within the seven transmembrane receptor family. Among several other regions, the N-terminus of these receptors is believed to be responsible for important specific hormone-receptor contact sites. Recombinant filamentous phages displaying at their surface three overlapping N-terminal decapeptides of the FSH receptor, peptides A18-27, B25-34 and C29-38 were constructed. Ewes and female mice were immunized against the three FSH receptor (FSHR) recombinant phages. Immunoglobulins purified from immunized animals were analyzed for their biochemical properties on a Chinese hamster ovary cell line expressing the porcine FSH receptor. AntiA and antiB immunoglobulins (IgGs) behave as antagonists for 125I-FSH binding and for FSH-dependent cAMP production, while antiC IgGs did not compete for hormone binding. By contrast, antibodies against the C29-38 peptide displayed FSH agonist activity and stimulated the FSH receptor, whereas antiA and antiB IgGs did not. Furthermore, when the FSHR phages were used as peptidic vaccines, they induced a reversible inhibition of ovulation rate in ewes, and impaired fertility in female mice.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10194518&dopt=Abstract

IPPF Med Bull. 1992 Dec;26(6):1-3.
Injectable contraception: the USA perspective.

Kaunitz AM.

PIP: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) is used for contraception by 8-9 million women in more than 90 countries, including the US, as of January 1993. Pharmacologically active levels of DMPA persist for 3-4 months following injection. A 150 mg dose is used most often for high contraceptive efficacy every 3 months. Norethindrone enanthate (NET-EN, Noristerat) is somewhat less widely used and is not marketed in the US. Injectables act primarily by inhibiting ovulation, lowering the levels of follicle-stimulating hormone and luteinizing hormone. Approximately 50% of women using DMPA for 1 year report amenorrhea whose occurrence is less frequent with NET-EN. Menstrual changes are the most frequent causes of discontinuation of injectables. In cases of heavy bleeding it is appropriate to undergo gynecological examination to rule out unrelated conditions, such as vaginitis, cervicitis, or cervical lesions. The use of conjugated estrogen (12.5-2.5 mg daily) for 10-21 days will minimize bleeding. Some women using injectables experience headache, dizziness, bloating of the abdomen or breast, and mood changes. Long-term use of DMPA or NET-EN can often result in 1-3 kg weight gain. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives was launched in 1979 to examine cancer risks with the use of DMPA in Thailand, Mexico, and Kenya. The relative risk of breast cancer was 1.21, which was statistically not significant. In women diagnosed with breast cancer under age 35, short-term exposure to DMPA was associated with a slightly increased breast cancer risk, which, however, was not associated with duration of use. DMPA dramatically lowers the risk of endometrial cancer for at least eight years following discontinuation of its use. DMPA did not alter the risk of cervical cancer. Fertility returns in 70% of former users within 12 months; it is suitable for postpartum and lactating women, and provides other noncontraceptive benefits.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12346920&dopt=Abstract

Soc Change. 1996 Sep-Dec;26(3-4):88-99.
Male involvement and contraceptive methods for men: present and future.

Ringheim K.

PIP: The four standard male methods of fertility control--coitus interruptus, periodic abstinence, vasectomy, and condoms--account for only 30% of worldwide contraceptive use. The failure of family planning programs to acknowledge the crucial role played by men in the contraceptive decision-making process may be responsible, in part, for stagnant contraceptive prevalence rates in some parts of the world. The development of new, reversible male methods of fertility control with adequate acceptability levels represents a major challenge in the field of reproductive health. Most promising are hormonal methods such as combined androgens and progestogens given as injections or implants. These hormones suppress spermatogenesis by inhibiting luteinizing hormone and follicle-stimulating hormone. Volunteers for early clinical trials of male hormonal methods have been motivated by a desire to share responsibility for family planning and concerns about side effects associated with many female methods. Genetic and immunologic approaches have long-term potential, but remain at the basic science level. Despite a trend toward increasing public support for male involvement in family planning, a strong financial commitment to research on the part of the pharmaceutical industry is lacking and impedes progress in this area.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12348919&dopt=Abstract

Contracept Technol Update. 2000 Mar;21(3):33.
How to make the switch from OC use to HRT.

[No authors listed]

PIP: This article discusses some approaches recommended by three physicians that will help women make the transition from oral contraceptive (OC) use to hormone replacement therapy (HRT). Andrew Kaunitz does not believe that checking follicle-stimulating hormone (FSH) levels to determine when OC users have become menopausal is useful. This approach is based on the following observations: 1) in premenopausal women, FSH levels vary and a single elevated FSH level does not reliably document that contraception is no longer needed; 2) checking of FSH levels on the 5th-7th day of the pill-free interval is not useful, since sex steroids in OCs suppress FSH blood levels for far longer than 7 days; and 3) about 50% of 52-year-old OC users are not yet menopausal, but by age 55 a great majority of women are menopausal. Kaunitz's approach to OC/HRT transition among older women is continuation of OCs until their mid-50s, then switching them to HRT. Meanwhile, Leon Speroff recommends to begin measuring FSH levels of the patient at age 50 on Friday of the pill-free week and when it is greater than 20; a switch to a regular postmenopausal regimen is then made. Felicia Stewart lets her patients select the transition option that best fits their needs.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12349549&dopt=Abstract

Concerned about losing hair? Hair loss and baldness is indeed a visible problem, and could be more than just the matter of change in appearance.
Saw palmetto berry is a widely known herbal supplement for hair loss problems. However, there are a number of great anecdotal herbs that people used for thousands of years stop hair loss and start hair growth. Numerous anecdotal cases have demonstrated that this herbal formula based on Chinese herbs actually improves the age-related hair thinning and hair loss for a significant fraction of people who take it diligently. It is unknown how Hair Million herbs actually stop hair loss, and promote hair growth, No scientific research or placebo controlled clinical trials have been conducted. Nonetheless, a number of people agree that it works.

DreamPharm Online Healthy Supplements || Constipation relief, laxative, colon cleansing || Paxil Online || Buspar Online || Propecia Online || Flexeril Online || Tramadol Online || Lutein || Natural herbal formula for hair loss problems ||